How Does Bristol-Myers Squibb Company (BMY) Stack Up Right Now?

Bristol-Myers Squibb Company (BMY) is an interesting player in the Healthcare space, with a focus on Drug Manufacturers – Major. The stock has been active on the tape, currently trading at $57.99, up from yesterday’s close by 1.52%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.

Fundamental Analysis

Money managers are always interested in a company that can find the right recipe of fundamental data because it reflects something important going on underneath the surface. Bristol-Myers Squibb Company (BMY) currently trades with a market capitalization of $97.08 Billion. That value represents a market adjusting for revenues that have been growing by 22.30 % on a quarterly year/year basis as of the company’s last quarterly report.



The balance sheet health of any company plays a key role in its ability to meet its obligations and maintain the faith of its investment base. For BMY, the company currently has $4.24 Billion of cash on the books, which is offset by $992 Million current liabilities. You can get a sense of how sustainable that is by a levered free cash flow of $1.64 Billion over the past twelve months. Generally speaking, earnings are expected to fall in coming quarters. Analysts are forecasting earnings of $0.74 on a per share basis this quarter. Perhaps, that suggests something about why 0.33% of the outstanding share supply is held by institutional investors.

Technical Analysis

We’ve taken a serious look at this stock from a fundamental perspective, but the tale of the tape may offer more hints about what lies under the surface. Looking at the stock’s movement on the chart, Bristol-Myers Squibb Company recorded a 52-week high of $76.09. It is now trading 18.1% off that level. The stock is trading $54.69 its 50-day moving average by -3.3%. The stock carved out a 52-week low down at $46.01.

In recent action, Bristol-Myers Squibb Company (BMY) has made a move of +11.52% over the past month, which has come on Strong relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 28.37, and it’s gotten there by action that has been more volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 0.95% with $1.67 Billion sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of BMY.

SHARE
Previous articleDigging Up the Facts on Chevron Corporation (CVX)
Next articleDrilling Down Into MGM Resorts International (MGM)